financetom
Business
financetom
/
Business
/
BRIEF-Agomab Therapeutics Files For Us IPO - SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Agomab Therapeutics Files For Us IPO - SEC Filing
Mar 11, 2026 12:54 AM

Jan 16 (Reuters) - SEC Filing:

* AGOMAB THERAPEUTICS FILES FOR ‌US IPO - ​SEC FILING

* AGOMAB ‍THERAPEUTICS NV ⁠SAYS ⁠J.P. MORGAN ,MORGAN STANLEY,

LEERINK

PARTNERS AND ‌VAN ​LANSCHOT KEMPEN ARE UNDERWRITERS TO ⁠IPO

* ‍AGOMAB ​THERAPEUTICS NV: APPLIED TO LIST ADSS ‍ON NASDAQ,

UNDER

SYMBOL "AGMB"

* AGOMAB THERAPEUTICS NV: 5.73% OF ​COMMON ‍SHARES

BENEFICIALLY

OWNED BY PFIZER BEFORE ​OFFERING

* AGOMAB THERAPEUTICS NV: 7.48% OF COMMON SHARES

BENEFICIALLY

OWNED BY ​SANOFI FOREIGN PARTICIPATIONS B.V BEFORE OFFERING

Source ‍text:

Further company coverage: [ ]

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved